Skip to main content
. 2019 Sep 4;6(9):ofz314. doi: 10.1093/ofid/ofz314

Figure 2.

Figure 2.

Clinical efficacy. Kaplan-Meier survival analysis of artesunate-atovaquone-proguanil (ASAP) efficacy over 42 days vs atovaquone-proguanil (AP) alone at 2 sites in Cambodia based on number of volunteers remaining malaria free at each interval (inset). A, Overall (log-rank P value for difference = .617). B, Anlong Veng site. C, Kratie site. There were no statistical differences in outcomes for AP (P = .663) or ASAP (P = .317) by location.